Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Raw Materials: 2011-2016

Historic Raw Materials for Rockwell Medical (RMTI) over the last 4 years, with Sep 2016 value amounting to $8.6 million.

  • Rockwell Medical's Raw Materials rose 68.47% to $8.6 million in Q3 2016 from the same period last year, while for Sep 2016 it was $8.6 million, marking a year-over-year increase of 68.47%. This contributed to the annual value of $5.5 million for FY2015, which is 150.55% up from last year.
  • Rockwell Medical's Raw Materials amounted to $8.6 million in Q3 2016, which was up 6.96% from $8.1 million recorded in Q2 2016.
  • In the past 5 years, Rockwell Medical's Raw Materials registered a high of $8.6 million during Q3 2016, and its lowest value of $1.0 million during Q4 2012.
  • Its 3-year average for Raw Materials is $4.4 million, with a median of $4.6 million in 2015.
  • Per our database at Business Quant, Rockwell Medical's Raw Materials declined by 2.33% in 2014 and then spiked by 273.66% in 2015.
  • Quarterly analysis of 5 years shows Rockwell Medical's Raw Materials stood at $1.0 million in 2012, then increased by 12.19% to $1.1 million in 2013, then skyrocketed by 92.26% to $2.2 million in 2014, then surged by 150.55% to $5.5 million in 2015, then soared by 68.47% to $8.6 million in 2016.
  • Its Raw Materials was $8.6 million in Q3 2016, compared to $8.1 million in Q2 2016 and $6.7 million in Q1 2016.